StartsideGIFOF • OTCMKTS
add
Grifols SA Preference Shares Class B
Forrige sluttkurs
7,42 $
Årsintervall
5,58 $ - 9,40 $
Markedsverdi
5,97 mrd. USD
Gjennomsnittlig volum
10,00
P/E-tall
-
Utbytte
-
Markedsnyheter
Økonomi
Resultatregnskap
Omsetning
Nettoomsetning
(EUR) | sep. 2024info | Endring år til år |
---|---|---|
Omsetning | 1,79 mrd. | 12,24 % |
Driftskostnader | 376,78 mill. | −3,08 % |
Nettoomsetning | 51,69 mill. | −13,19 % |
Netto resultatmargin | 2,88 | −22,79 % |
Fortjeneste per aksje | — | — |
EBITDA | 468,09 mill. | 33,73 % |
Faktisk avgiftssats | 31,35 % | — |
Balanseregnskap
Totale aktiva
Totale passiva
(EUR) | sep. 2024info | Endring år til år |
---|---|---|
Kontant / kortsiktige inv. | 806,74 mill. | 66,60 % |
Totale aktiva | 20,28 mrd. | −8,07 % |
Totale passiva | 12,29 mrd. | −8,95 % |
Total egenkapital | 8,00 mrd. | — |
Utestående aksjer | 679,63 mill. | — |
P/B-forhold | 0,94 | — |
Avkastning på aktiva | 4,22 % | — |
Avkastning på kapital | 4,78 % | — |
Kontantstrøm
Netto kontantstrøm
(EUR) | sep. 2024info | Endring år til år |
---|---|---|
Nettoomsetning | 51,69 mill. | −13,19 % |
Kontantstrøm fra drift | 299,61 mill. | 92,51 % |
Kontanter fra investering | −196,40 mill. | −59,83 % |
Kontanter fra finansiering | −1,56 mrd. | −1 860,81 % |
Netto kontantstrøm | −1,47 mrd. | −3 652,69 % |
Fri kontantstrøm | 243,60 mill. | 627,76 % |
Om
Grifols, S.A. is a global healthcare company and manufacturer of plasma-derived medicines founded in Barcelona, Spain, in 1909. With a workforce of over 23,000employees, Grifols serves more than 110 countries and regions and maintains a direct presence in over than 30.
Principally a producer of blood plasma–based products, a field in which it is the European leader and third largest worldwide, and other biopharmaceutical solutions, the company is also a leader in transfusion medicine, supplying devices, instruments and reagents for clinical testing laboratories, in addition to clinical diagnostic technologies. Its portfolio of solutions is designed to enhance safety from donation to transfusion. Grifols also provides high-quality biological supplies for life-science research, clinical trials and for manufacturing pharmaceutical and diagnostic products. Additionally, the company supply tools, information and services that enable hospitals, pharmacies and healthcare professionals to deliver expert medical care. Wikipedia
Administrerende direktør
Grunnlagt
18. nov. 1940
Nettsted
Ansatte
23 000